Get started
Author

Salvatore Crisafulli

Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis
2020 · Salvatore Crisafulli, Janet Sultana, et al. · Orphanet Journal of Rare Diseases · 503
PDF
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration
2024 · Michele Fusaroli, Francesco Salvo, et al. · Drug Safety · 365
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement
2024 · Michele Fusaroli, Francesco Salvo, et al. · Drug Safety · 287
PDF
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
2024 · Paola Maria Cutroneo, Daniele Sartori, et al. · Frontiers in Drug Safety and Regulation · 221
PDF
The economic burden of preventable adverse drug reactions: a systematic review of observational studies
2018 · D Formica, J Sultana, et al. · Expert Opinion on Drug Safety · 211
Challenges for Drug Repurposing in the COVID-19 Pandemic Era
2020 · Janet Sultana, Salvatore Crisafulli, et al. · Frontiers in Pharmacology · 147
PDF
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines
2020 · Janet Sultana, Paola Maria Cutroneo, et al. · Drug Safety · 141
PDF
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety
2021 · Nicoletta Luxi, Alexia Giovanazzi, et al. · Drug Safety · 139
Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta‐analysis
2024 · Massimo Carollo, Salvatore Crisafulli, et al. · Journal of the American Geriatrics Society · 99
Global epidemiology of acromegaly: a systematic review and meta-analysis
2021 · Salvatore Crisafulli, Nicoletta Luxi, et al. · European Journal of Endocrinology · 85
Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia
2021 · Guido Gembillo, Ylenia Ingrasciotta, et al. · International Journal of Molecular Sciences · 85
PDF
A New Era of Pharmacovigilance: Future Challenges and Opportunities
2022 · Gianluca Trifirò, Salvatore Crisafulli · Frontiers in Drug Safety and Regulation · 69
PDF
Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks
2020 · Salvatore Crisafulli, Valentina Isgrò, et al. · BioDrugs · 66
PDF
Pharmacokinetics of new oral anticoagulants: implications for use in routine care
2018 · Ylenia Ingrasciotta, Salvatore Crisafulli, et al. · Expert Opinion on Drug Metabolism & Toxicology · 60
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
2020 · Gianluca Trifirò, Marco Massari, et al. · Drug Safety · 53
PDF
Global Cushing’s disease epidemiology: a systematic review and meta-analysis of observational studies
2022 · G. Giuffrida, S. Crisafulli, et al. · Journal of Endocrinological Investigation · 50
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future
2024 · Salvatore Crisafulli, Brigida Boccanegra, et al. · CNS Drugs · 40
Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of Pharmacovigilance
2025 · Salvatore Crisafulli, Andrew Bate, et al. · Drug Safety · 39
PDF
Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance
2022 · Salvatore Crisafulli, Eugenio Santoro, et al. · Frontiers in Drug Safety and Regulation · 38
PDF
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health
2024 · Carlotta Lunghi, Maria Rosa Valetto, et al. · Drug Safety · 35
PDF
Global incidence and prevalence of differentiated thyroid cancer in childhood: systematic review and meta-analysis
2023 · Mariacarla Moleti, Tommaso Aversa, et al. · Frontiers in Endocrinology · 34
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study
2019 · Salvatore Crisafulli, Janet Sultana, et al. · Expert Opinion on Drug Safety · 34
An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting
2023 · Salvatore Crisafulli, Zakir Khan, et al. · Expert Opinion on Drug Safety · 26
Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective
2022 · Salvatore Crisafulli, Elisabetta Poluzzi, et al. · Frontiers in Drug Safety and Regulation · 25
PDF
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
2020 · the Italian Society of Pharmacology, Gianluca Trifirò, et al. · Drug Safety · 25
PDF
Works count: 74
Citation count: 3,263
H-index: 25
I10-index: 41
Year
Topic
Type